AMBO - GNW SELB among premarket losers
Zosano Pharma (ZSAN) -53% after FDA discipline review letter for Qtrypta.Selecta Biosciences (SELB) -44% after SEL-212 misses primary endpoint in mid-stage gout study.LogicBio Therapeutics (LOGC) -26% on launch of equity offering.ChinaNet Online Holdings (CNET) -22%.CynergisTek (CTEK) -16%.SPI Energy (SPI) -16% after pricing direct offering.Soleno Therapeutics (SLNO) -14% pared yesterday's gains after DCCR study shows positive outcome in obesity disorder.Nano Dimension (NNDM) -13% after pricing direct offering.Genworth Financial (GNW) -13% after providing further updates regarding acquisition.Ambow Education (AMBO) -12%.Iterum Therapeutics (ITRM) -11%.CTI BioPharma (CTIC) -9%.PEDEVCO (PED) -9%.Allena Pharmaceuticals (ALNA) -6%.Tantech Holdings (TANH) -6% on H1 results.Sorrento Therapeutics (SRNE) -5%.Tuniu (TOUR) -5%.
For further details see:
GNW, SELB among premarket losers